CC
ADVM

Commodore Capital’s Adverum Biotechnologies ADVM Stock Holding History

Commodore Capital’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-657,333
Closed -$9.29M – 37
2024
Q1 		$9.29M Sell
657,333
-342,667
-34% -$5.21M 0.62% 31
2023
Q4 		$7.53M Hold
1,000,000
– – 0.66% 29
2023
Q3 		$15M Hold
1,000,000
– – 1.75% 19
2023
Q2 		$15.9M Buy
1,000,000
+500,000
+100% +$5.26M 1.79% 18
2023
Q1 		$3.59M Buy
+500,000
New +$3.54M 0.55% 28

Other funds holding ADVM

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return